These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37844109)

  • 21. Supervised consumption site enables cost savings by avoiding emergency services: a cost analysis study.
    Khair S; Eastwood CA; Lu M; Jackson J
    Harm Reduct J; 2022 Mar; 19(1):32. PubMed ID: 35346223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determining the feasibility for an overdose prevention line to support substance users who use alone.
    Ritchie K; Ghosh SM
    Harm Reduct J; 2022 Aug; 19(1):92. PubMed ID: 35986328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "That's a double-edged sword": Exploring the integration of supervised consumption services within community health centres in Toronto, Canada.
    Bardwell G; Strike C; Mitra S; Scheim A; Barnaby L; Altenberg J; Kerr T
    Health Place; 2020 Jan; 61():102245. PubMed ID: 31740126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To what extent do supervised drug consumption services incorporate non-injection routes of administration? A systematic scoping review documenting existing facilities.
    Speed KA; Gehring ND; Launier K; O'Brien D; Campbell S; Hyshka E
    Harm Reduct J; 2020 Oct; 17(1):72. PubMed ID: 33028363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation contexts and the impact of policing on access to supervised consumption services in Toronto, Canada: a qualitative comparative analysis.
    Bardwell G; Strike C; Altenberg J; Barnaby L; Kerr T
    Harm Reduct J; 2019 May; 16(1):30. PubMed ID: 31046759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "You don't have to squirrel away in a staircase": Patient motivations for attending a novel supervised drug consumption service in acute care.
    Kosteniuk B; Salvalaggio G; McNeil R; Brooks HL; Dong K; Twan S; Brouwer J; Hyshka E
    Int J Drug Policy; 2021 Oct; 96():103275. PubMed ID: 34020865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in Northern Ontario, Canada.
    Russell C; Neufeld M; Sabioni P; Varatharajan T; Ali F; Miles S; Henderson J; Fischer B; Rehm J
    PLoS One; 2019; 14(12):e0225548. PubMed ID: 31805082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives of Canadian Healthcare and Harm Reduction Workers on Mobile Overdose Response Services: A Qualitative Study.
    Sedaghat N; Seo B; Rider N; Rioux W; Ghosh SM
    Subst Use Addctn J; 2024 Jul; 45(3):506-514. PubMed ID: 38525593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia.
    O'Rourke A; White RH; Park JN; Rodriguez K; Kilkenny ME; Sherman SG; Allen ST
    Harm Reduct J; 2019 Aug; 16(1):51. PubMed ID: 31470864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stakeholder preferences for supervised consumption site design, staff, and ancillary services: A scoping review of feasibility studies.
    Kryszajtys DT; Xavier J; Rudzinski K; Guta A; Chan Carusone S; Strike CJ
    Drug Alcohol Depend; 2022 Jan; 230():109179. PubMed ID: 34847503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia.
    Roxburgh A; Jauncey M; Day C; Bartlett M; Cogger S; Dietze P; Nielsen S; Latimer J; Clark N
    Harm Reduct J; 2021 Feb; 18(1):20. PubMed ID: 33596940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Operating an overdose prevention site within a temporary emergency shelter during the COVID-19 pandemic.
    Galarneau LR; Speed K; Taylor M; Hyshka E
    Can J Public Health; 2023 Oct; 114(5):787-795. PubMed ID: 37462841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration.
    Wolfson-Stofko B; Elliott L; Bennett AS; Curtis R; Gwadz M
    Int J Drug Policy; 2018 Dec; 62():67-73. PubMed ID: 30359875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implementation and sustainability of safe consumption sites: a qualitative systematic review and thematic synthesis.
    Yoon GH; Levengood TW; Davoust MJ; Ogden SN; Kral AH; Cahill SR; Bazzi AR
    Harm Reduct J; 2022 Jul; 19(1):73. PubMed ID: 35790994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practices of care among people who buy, use, and sell drugs in community settings.
    Kolla G; Strike C
    Harm Reduct J; 2020 May; 17(1):27. PubMed ID: 32381011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans.
    Eydt E; Glegg S; Sutherland C; Meador K; Trew M; Perreault M; Goyer MÈ; Le Foll B; Turnbull J; Fairbairn N
    CMAJ Open; 2021; 9(1):E115-E124. PubMed ID: 33622764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical studies of harm reduction: Overdose response in uncertain political times.
    Watson TM; Kolla G; van der Meulen E; Dodd Z
    Int J Drug Policy; 2020 Feb; 76():102615. PubMed ID: 31837567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'It's too much, I'm getting really tired of it': Overdose response and structural vulnerabilities among harm reduction workers in community settings.
    Kolla G; Strike C
    Int J Drug Policy; 2019 Dec; 74():127-135. PubMed ID: 31590088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.